What is NovoLog/NovoRapid?
Insulin aspart is a rapid-acting insulin analog marketed as NovoLog/NovoRapid by Novo Nordisk. It is a synthetic type of insulin that has been modified to perform a certain task. A single amino acid has been traded to help the medication be absorbed rapidly into the blood stream. Therefore, it begins working in minutes, which enables patients to take insulin and consume food right away. Fast-acting insulin analogs act the same way that insulin acts in individuals without diabetes. Insulin allows individuals with both type 1 and type 2 diabetes to control their blood sugar levels.
Similarities between NovoRapid vs NovoLog
NovoLog and NovoRapid are both brand names for Novo Nordisk’s fast-acting insulin aspart. NovoLog is the name used in the United States, and NovoRapid is the name used outside of the United States.
Both medications allow for an adjustable dosing schedule, which gives patients the ability to adjust their insulin according to changes in their eating habits. The medication begins to take effect within 5 to 10 minutes, and it can last for 3 to 5 hours. Ordinarily, it is taken in conjunction with longer-acting insulin.
This insulin must be injected or given through an IV. Insulin aspart should not be mixed or diluted with other insulin when using an insulin pump. You may need to carry a glucagon emergency kit in case you experience hypoglycemia.
This medicine may induce common injection-related reactions, including pain, irritation, and redness. Severe side effects are rare when using insulin aspart. If you experience hypoglycemia, signs of low potassium, or other severe side effects, you should seek medical attention. Do not use this medication if you are allergic to insulin aspart. As well, speak to your doctor if you have thyroid problems, or kidney or liver disease.